<table frame="void" id="b5991e7e-4be4-4468-bb23-a444cb970eaa" width="583" xmlns="urn:hl7-org:v3" xmlns:v="http://validator.pragmaticdata.com/result" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption> Table 1: 	Select Mean (±S.D.) Metformin Pharmacokinetic Parameters Following Single or Multiple Oral Doses of Metformin</caption>
<thead>
<tr>
<td align="left" stylecode="LruleRruleToprule" valign="top">
<content stylecode="bold">Subject Groups:</content>
</td>
<td align="left" stylecode="LruleRruleToprule" valign="top">
<content stylecode="bold">C</content>
<content stylecode="bold">
<sub>max</sub>
</content>
<content stylecode="bold">
<sup>b(</sup>
</content>
<content stylecode="bold">μg/mL)</content>
</td>
<td align="left" stylecode="LruleRruleToprule" valign="top">
<content stylecode="bold">T</content>
<content stylecode="bold">
<sub>max</sub>
</content>
<content stylecode="bold">
<sup>c</sup>
</content>
<content stylecode="bold"> (hrs) </content>
</td>
<td align="left" stylecode="LruleRruleToprule" valign="top">
<content stylecode="bold">Renal</content>
</td>
</tr>
<tr>
<td align="left" stylecode="BotruleLruleRrule" valign="top">
<content stylecode="bold">MetforminDose </content>
<content stylecode="bold">
<sup>a </sup>
</content>
<content stylecode="bold">(Number of Subjects) </content>
</td>
<td align="left" stylecode="BotruleLruleRrule" valign="top"></td>
<td align="left" stylecode="BotruleLruleRrule" valign="top"></td>
<td align="left" stylecode="BotruleLruleRrule" valign="top">
<content stylecode="bold">Clearance (mL/min)</content>
</td>
</tr>
</thead>
<tfoot>
<tr>
<td align="left" colspan="4" stylecode="Toprule" valign="top">
<sup>a </sup>All doses given fasting except the first 18 doses of the multiple-dose studies </td>
</tr>
<tr>
<td align="left" colspan="4" valign="top">
<sup>b </sup>Peak plasma concentration </td>
</tr>
<tr>
<td align="left" colspan="4" valign="top">
<sup>c</sup> Time to peak plasma concentration </td>
</tr>
<tr>
<td align="left" colspan="4" valign="top">
<sup>d</sup> SD=single dose </td>
</tr>
<tr>
<td align="left" colspan="4" valign="top">
<sup>e</sup> Combined results (average means) of five studies: mean age 32 years (range 23-59 years)  </td>
</tr>
<tr>
<td align="left" colspan="4" valign="top">
<sup>f </sup>Kinetic study done following dose 19, given fasting </td>
</tr>
<tr>
<td align="left" colspan="4" valign="top">
<sup>g</sup>Elderly subjects, mean age 71 years (range 65-81 years) </td>
</tr>
<tr>
<td align="left" colspan="4" valign="top">
<sup>h</sup> CL<sub>cr</sub>=creatinine clearance normalized to body surface area of 1.73 m<sup>2</sup>
</td>
</tr>
</tfoot>
<tbody>
<tr>
<td align="left" stylecode="BotruleLruleRruleToprule" valign="top">
<content stylecode="bold">Healthy, Nondiabetic Adults:</content>
<br/>500 mg SD d (24)<br/> 850 mg SD (74) <sup>e</sup>
<br/>850 mg t.i.d. for 19 doses <sup>f</sup> (9)</td>
<td align="center" stylecode="BotruleLruleRruleToprule" valign="top">
<br/>1.03 (±0.33) <br/>1.60 (±0.38) <br/>2.01 (±0.42)</td>
<td align="center" stylecode="BotruleLruleRruleToprule" valign="top">
<br/>2.75 (±0.81) <br/>2.64 (±0.82) <br/>1.79 (±0.94)</td>
<td align="center" stylecode="BotruleLruleRruleToprule" valign="top">
<br/>600 (±132)<br/> 552 (±139)<br/> 642 (±173)</td>
</tr>
<tr>
<td align="left" stylecode="BotruleLruleRruleToprule" valign="top">
<content stylecode="bold">Adults with Type 2 Diabetes:</content>
<br/>850 mg SD (23)<br/>850 mg t.i.d. for 19 doses <sup>f</sup> (9)</td>
<td align="center" stylecode="BotruleLruleRruleToprule" valign="top">
<br/>1.48 (±0.5) <br/>1.90 (±0.62)</td>
<td align="center" stylecode="BotruleLruleRruleToprule" valign="top">
<br/>3.32 (±1.08) <br/>2.01 (±1.22)</td>
<td align="center" stylecode="BotruleLruleRruleToprule" valign="top">
<br/>491 (±138)<br/> 550 (±160)</td>
</tr>
<tr>
<td align="left" stylecode="BotruleLruleRruleToprule" valign="top">
<content stylecode="bold">Elderly</content>
<content stylecode="bold">
<sup>g</sup>
</content>
<content stylecode="bold">, Healthy Nondiabetic</content>
<br/>Adults:<br/> 850 mg SD (12)</td>
<td align="center" stylecode="BotruleLruleRruleToprule" valign="top">
<br/>
<br/>2.45 (±0.70)</td>
<td align="center" stylecode="BotruleLruleRruleToprule" valign="top">
<br/>
<br/>2.71 (±1.05)</td>
<td align="center" stylecode="BotruleLruleRruleToprule" valign="top">
<br/>
<br/>412 (±98)</td>
</tr>
<tr>
<td align="left" stylecode="BotruleLruleRruleToprule" valign="top">
<content stylecode="bold">Renal-impaired Adults: 850 mg SD</content>
<content stylecode="bold">
<br/>
</content>Mild (CL<sub>cr</sub>
<sup>h</sup> 61-90 mL/min) (5)<br/>Moderate (CL<sub>cr</sub> 31-60mL/min)(4)<br/>Severe (CL<sub>cr</sub> 10-30 mL/min) (6)</td>
<td align="center" stylecode="BotruleLruleRruleToprule" valign="top">
<br/>1.86 (±0.52)<br/>4.12 (±1.83)<br/>3.93 (±0.92)</td>
<td align="center" stylecode="BotruleLruleRruleToprule" valign="top">
<br/>3.20 (±0.45)<br/>3.75 (±0.50)<br/>4.01 (±1.10)</td>
<td align="center" stylecode="BotruleLruleRruleToprule" valign="top">
<br/>384 (±122)<br/> 108 (±57)<br/> 130 (±90)</td>
</tr>
</tbody>
</table>